Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, has appointed Matthew Casbon as Vice President of Sales, Marketing and Training, and Matthew Rysavy as Vice President of Market Access and Trade.   They each bring approximately 25 years of commercialization expertise spanning marketing, sales, training, market access, trade and business development across a variety of therapeutic areas.   Chris Martin, senior vice president of commercial, said: “W...